Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LY2510924
Trade Name
Synonyms LY-2510924|LY 2510924
Drug Descriptions

LY2510924 is a selective CXCR4 antagonist that prevents SDF-1 binding, potentially resulting in decreased tumor cell migration (PMID: 25504752, PMID: 32219196).

DrugClasses CXCR4 Inhibitor 15
CAS Registry Number 1088715-84-7
NCIT ID C106253


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cytarabine + Idarubicin + LY2510924 Cytarabine Idarubicin LY2510924 0 1
Durvalumab + LY2510924 Durvalumab LY2510924 0 1
LY2510924 LY2510924 0 0
LY2510924 + Sunitinib LY2510924 Sunitinib 0 0

Additional content available in CKB BOOST